Asia-Pacific embolic protection devices market was valued at $167.4 million in 2024 and is projected to reach $421.3 million by 2035, growing at a CAGR of 8.8% during the forecast period (2025–2035). The Asia-Pacific region is rapidly emerging as a significant medical tourism hub. For instance, the Indian medical tourism market, valued at $2.89 billion in 2020, is projected to reach $13.42 billion by 2026, driven by the “Heal in India” initiative of the government. As quality results and appealing claims are making it attractive for Western patients to take treatment from here. Good results support these appealing claims, as the use of embolic protection devices in heart valve replacements is seen as a core part of the treatment, ensuring the minimum possibility of stroke, rather than an add-on cost. This vision is driving the growth of this market.

US medical robotics market was valued at $9.0 billion in 2025 and is growing at a CAGR of 15.2% during the forecast period (2026-2035). The US medical robotics market is rapidly evolving, driven by increasing demand for minimally invasive surgeries and advanced patient care. An aging population and rising prevalence of chronic diseases are fueling adoption across surgical, diagnostic, and rehabilitation applications. Innovations in artificial intelligence, machine learning, and haptic feedback are enhancing precision and efficiency in procedures.

US eHealth market was valued at $19.6 billion in 2025 and is growing at a CAGR of 12.1% during the forecast period (2026-2035). The US eHealth market is undergoing steady transformation as digital technologies become increasingly embedded across healthcare delivery and management. Rising adoption of telehealth and virtual care models reflects a broader shift toward more accessible and patient-centric services. 

North American medical robotics market was valued at $9.7 billion in 2025 and is growing at a CAGR of 14.9% during the forecast period (2026-2035). The North American medical robotics market is expanding as hospitals and clinics adopt automation to improve surgical precision and operational efficiency. Advances in AI, machine learning, and sensor technologies are enabling robots to move beyond surgery into rehabilitation, diagnostics, and hospital logistics. Rising demand for minimally invasive procedures and an aging population are driving market growth. Integration with electronic health records and teleoperation capabilities is becoming increasingly important. Hospitals are also focused on value-based care, emphasizing better outcomes and cost efficiency. High costs and the need for specialized training remain key challenges. Collaboration among technology developers, clinicians, and regulators is shaping the future adoption of medical robotics in the region.

UK eHealth market was valued at $2.4 billion in 2025 and is growing at a CAGR of 11.7% during the forecast period (2026-2035). The UK eHealth market is evolving steadily as digital solutions become integral to healthcare delivery and system efficiency. Growing adoption of telehealth and virtual consultations is supporting improved access to care and reducing pressure on physical healthcare infrastructure.

US drug discovery informatics market was valued at $1,466.8 million in 2025 and is projected to reach $3,252.3 million by 2035, growing at a CAGR of 8.3% during the forecast period (2026–2035). Drug discovery informatics in the United States encompasses the use of advanced computational modeling, data analytics, and integrated informatics platforms to support critical stages of drug development, including virtual screening, molecular docking, structure-based drug design, sequencing and target data analysis, and library and database management. 

North American eHealth market was valued at $21.4 billion in 2025 and is growing at a CAGR of 12.0% during the forecast period (2026-2035). The North American eHealth market is rapidly advancing, driven by telehealth, remote monitoring, electronic health records, and AI?enabled care. Supportive policies, strong healthcare infrastructure, and high patient adoption are accelerating digital health integration. Telemedicine and mobile health apps are increasingly used for chronic disease management and preventive care, while investments in AI and connected devices enhance efficiency and patient outcomes. Healthcare providers are further leveraging data analytics to improve decision-making and personalize treatment, and collaborations between tech companies and hospitals are fostering innovation. This combination of technology, policy support, and patient engagement positions North America as a leader in digital healthcare innovation.

US AI in e-commerce market was valued at $2,826.58 million in 2025 and is projected to reach $13,941.03 million by 2035, growing at a CAGR of 15.7% during the forecast period (2026–2035).  The US e-commerce market is experiencing significant adoption of conversational AI and virtual assistants as companies seek to enhance customer experience and operational efficiency.

UK drug discovery informatics market was valued at $242.2 million in 2025 and is projected to reach $502.1 million by 2035, growing at a CAGR of 7.6% during the forecast period (2026–2035). Drug discovery informatics in the UK involves the application of computational modeling, virtual screening, molecular docking, data integration, and advanced analytics to support drug discovery and development,

North America drug discovery informatics market was valued at $1,588.3 million in 2025 and is projected to reach $3,491.5 million by 2035, growing at a CAGR of 8.3% during the forecast period (2026–2035). Drug discovery informatics involves the application of computational modeling, advanced data analytics, and integrated databases to enhance drug development activities, including virtual screening, molecular docking, structure-based drug design, library and database preparation, and sequencing and target data analysis.